DAFNA Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.81M | Sell |
|
|||||
|
2022
Q4 | $4.31M | Buy |
|
|||||
|
2022
Q3 | $4.5M | Sell |
|
|||||
|
2022
Q2 | $4.38M | Buy |
|
|||||
|
2022
Q1 | $4.77M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $803K | Sell |
|
|||||
|
2021
Q1 | $1.93M | Buy |
|
|||||
|
2020
Q4 | $2.51M | Buy |
|
|||||
|
2020
Q3 | $907K | Sell |
|
|||||
|
2020
Q2 | $1.1M | Sell |
|
|||||
|
2020
Q1 | $1.45M | Buy |
|
|||||
|
2019
Q4 | $1.25M | Sell |
|
|||||
|
2019
Q3 | $4.09M | Buy |
|